TWYNEO

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jul 26, 2021

   5 yr ago

2. Today

3. Patent 12156946 expires

   Listed drug product patent expiration.

   Feb 03, 2028

   in 1 yr 8 mo

4. Patent 8617580 expires

   Listed drug product patent expiration.

   Feb 03, 2028

   in 1 yr 8 mo

5. Patent 9868103 expires

   Listed drug product patent expiration.

   Aug 08, 2028

   in 2 yr 2 mo

6. Patent 10653899 expires

   Listed drug product patent expiration.

   Dec 30, 2030

   in 4 yr 7 mo

7. Patent 11071878 expires

   Listed drug product patent expiration.

   Dec 30, 2030

   in 4 yr 7 mo

8. Patent 12070629 expires

   Listed drug product patent expiration.

   Dec 30, 2030

   in 4 yr 7 mo

9. Patent 12053546 expires

   Listed drug product patent expiration.

   Jun 29, 2032

   in 6 yr 1 mo

10. Patent 10420743 expires

    Listed method-of-use patent (U-3194) expiration.

    Jul 12, 2038

    in 12 yr 3 mo

11. Patent 12357602 expires

    Listed drug product patent expiration.

    Jul 12, 2038

    in 12 yr 3 mo

12. Patent 12295935 expires

    Listed method-of-use patent (U-3987) expiration.

    Dec 27, 2040

    in 14 yr 9 mo

13. Patent 12133919 expires

    Listed drug product patent expiration.

    May 23, 2041

    in 15 yr 2 mo

14. Patent 12257348 expires

    Listed drug product patent expiration.

    May 23, 2041

    in 15 yr 2 mo

15. Patent 12491163 expires

    Listed drug product patent expiration.

    May 23, 2041

    in 15 yr 2 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (13)